The new study found that a combination of MDMA and psychotherapy was more effective at relieving PTSD symptoms when compared to standard therapy.
MDMA is short for 3,4-methylenedioxy-methamphetamine. It’s a synthetic drug with both stimulant and psychedelic effects. It’s been used historically as a recreational drug, going under the nicknames of Mollyillegal controlled substance by the U.S. federal government since the 1980s. But for decades, some psychologists and researchers have experimented with using MDMA as a way to boost the potency of talk therapy, particularly for PTSD.
in Nature Medicine in 2021. But the new study, unlike the first, was able to include a more diverse group of participants this time around, an important consideration for the approval of any new drug or therapy. Though not everyone seems responsive to MDMA-assisted therapy, the treatment could provide a valuable new option for people who haven’t responded to existing medications or therapy.
MAPS is proceeding with its application and plans to submit for formal FDA approval before the end of 2023. If successful, MDMA-assisted therapy could be available to the public as early as next year.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
MDMA therapy for PTSD expected to get US approval after latest trialUS regulators could soon authorise MDMA-assisted psychotherapy for post-traumatic stress disorder after positive results in the largest clinical trial to date
Read more »
PTSD may be cured by ‘ecstasy’ therapy: breakthrough MDMA studyIf approved, MDMA “would be the first novel treatment for PTSD in over two decades,” said one expert. “PTSD patients can feel some hope.”
Read more »
Maker of MDMA-assisted PTSD treatment to seek US regulatory nodThe Multidisciplinary Association for Psychedelic Studies (MAPS) plans to file for regulatory approval for the party drug MDMA as a treatment for post-traumatic stress disorder in the United States later this year, in a potential boost to the nascent psychedelic therapeutics industry.
Read more »
Maker of MDMA-assisted PTSD treatment to seek US regulatory nod By ReutersMaker of MDMA-assisted PTSD treatment to seek US regulatory nod
Read more »
Impeachment Trial Day 8: Defense rests in Ken Paxton impeachment trial, closing arguments FridayThe eighth day of the impeachment trial of Ken Paxton continues in Austin on Wednesday.
Read more »
Impeachment Trial Day 7: House rests in Paxton impeachment, motion to end trial withdrawnThe seventh day of the impeachment trial of Ken Paxton continues in Austin on Wednesday.
Read more »